Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...
Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq. So what ...
Me is facing scrutiny, with some experts calling it the beginning of the end for the popular genetic testing company. It's ...
In this podcast, Motley Fool analyst Jason Moser and host Mary Long discuss the semiconductor supply chain, ASML's earnings, ...
The entire board of DNA testing company 23andMe resigned after a conflict with CEO Anne Wojcicki over her plan to take the ...
Boing Boing on MSN2d
23andMe's meltdown: How to protect your DNA from falling into wrong handsConsumer DNA testing company 23andMe is circling the drain. The company's CEO, Anne Wojcicki, plans to take the company ...
GlobalData on MSN2dIn Depth
Explainer: 23andme is about to collapse – what happens to all that DNA data?With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...
Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...
Ambience Healthcare - the leading clinical AI platform for scribing, point-of-care CDI, patient summaries, and referrals - today announced that it has received a 97.7%* Spotlight Report score from ...
2don MSNOpinion
Turmoil at 23andMe, and a lawsuit alleging that GEDmatch shares data with Facebook, highlights how far your genetic ...
Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...
Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback